• About us
• Contact

Advertisement

Collaboration › Details

PerkinElmer–JPMorgan Chase: investor conference, 202101 supply service PerkinElmer presents at JP Morgan Healthcare Conference 2021

 

	Period	2021-01-11
	Partner, 1st	PerkinElmer Inc. (NYSE: PKI)
	Group	PerkinElmer (Group)
	Partner, 2nd	J.P. Morgan Securities LLC
	Group	JPMorgan Chase (Group)
	Product	J.P. Morgan 39th Annual Healthcare Conference 2021 DIGITAL
	Product 2	biopharmaceutical

PerkinElmer, Inc.. (12/16/20). "Press Release: PerkinElmer to Present at J.P. Morgan Healthcare Conference". Waltham, MA.

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021 at 7:30 a.m. ET.

Prahlad Singh, president and chief executive officer of PerkinElmer, will provide an update on the Company and its strategic priorities.

A live audio webcast will be available on the Investors section of the Company’s website at www.perkinelmer.com. A replay of the presentation will be posted on the PerkinElmer website after the event and will be available for 90 days following.


About PerkinElmer

PerkinElmer, Inc. is a global leader focused on innovating for a healthier world. The Company reported revenue of approximately $2.9 billion in 2019, has about 14,000 employees serving customers in 190 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.


Investor Relations:
Bryan Kipp
+1-781-663-5583
Bryan.Kipp@perkinelmer.com

Media Relations:
Chet Murray
+1-781-663-5719
Chet.Murray@perkinelmer.com

Record changed: 2020-12-17

Advertisement

More documents for PerkinElmer (Group)

• [1] Moderna, Inc.. (8/17/22). "Press Release: James Mock Joins Moderna as Chief Financial Officer". Cambridge, MA....
• [2] PerkinElmer, Inc.. (7/26/21). "Press Release: PerkinElmer to Acquire Antibody and Reagent Leader BioLegend". Waltham, MA....
• [3] PerkinElmer, Inc.. (6/22/21). "Press Release: PerkinElmer Agrees to Acquire Viral Vector Gene Delivery Leader Sirion Biotech". Waltham, MA....
• [4] PerkinElmer, Inc.. (5/17/21). "Press Release: PerkinElmer to Acquire In-Vitro Diagnostics Company Immunodiagnostic Systems Holdings PLC". Waltham, MA....
• [5] PerkinElmer, Inc.. (5/12/21). "Press Release: PerkinElmer Expands Cell Biology Leadership with Agreement to Acquire Nexcelom Bioscience". Waltham, MA....
• [6] PerkinElmer, Inc.. (1/7/21). "Press Release: PerkinElmer to Acquire Oxford Immunotec Global plc". Waltham, MA & London....
• [7] PerkinElmer, Inc.. (12/16/20). "Press Release: PerkinElmer to Present at J.P. Morgan Healthcare Conference". Waltham, MA....
• [8] PerkinElmer, Inc.. (11/2/20). "Press Release: PerkinElmer to Acquire Cell Engineering Company Horizon Discovery for $383 Million (£296 Million)". Waltham, MA....
• [9] Lynch, Sara N. [Reuters]. (5/18/20). "News: Exclusive – U.S. Probes PerkinElmer's Role in Massive Medicare Fraud –Sources". Washington....
• [10] PerkinElmer, Inc.. (8/21/19). "Press Release: PerkinElmer Announces Leadership Succession Plan". Waltham, MA....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.